BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 7545641)

  • 1. Changes in prevalence of anti-HCV antibodies associated with preventive measures among hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Shimada H; Matsushita K; Ikezaki N; Nakano T; Sato T
    Hepatogastroenterology; 1995 Apr; 42(2):162-5. PubMed ID: 7545641
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of hepatitis C virus antibodies in hemodialysis patients and dialysis staff.
    Fujiyama S; Kawano S; Sato S; Tanaka M; Goto M; Taura Y; Sato T; Kawahara T; Mizuno K
    Hepatogastroenterology; 1992 Apr; 39(2):161-5. PubMed ID: 1378811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low prevalence of anti-hepatitis C virus antibodies in female hemodialysis patients without blood transfusion: a multicenter analysis.
    Nakayama E; Liu JH; Akiba T; Marumo F; Sato C
    J Med Virol; 1996 Mar; 48(3):284-8. PubMed ID: 8801291
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Hepatitis C: epidemiology and therapy--with special reference to long-term prognosis after IFN therapy].
    Fujiyama S; Tanaka M
    Rinsho Byori; 2000 Jan; 48(1):5-13. PubMed ID: 10756668
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibodies to hepatitis C virus by second generation test in hemodialyzed patients.
    Chauveau P; Courouce AM; Lemarec N; Naret C; Poignet JL; Girault A; Ramdame M; Delons S
    Kidney Int Suppl; 1993 Jun; 41():S149-52. PubMed ID: 7686591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Infection of hepatitis C virus in patients with chronic renal failure undergoing hemodialysis therapy and staff members].
    Miyasaka M
    Nihon Jinzo Gakkai Shi; 1991 Oct; 33(10):989-99. PubMed ID: 1722830
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibodies to hepatitis C virus: a cross-sectional study in patients attending a trauma unit or admitted to hospital for elective surgery.
    García-Bengoechea M; Emparanza JI; Sarriugarte A; Cortés A; Vega JL; González F; Arenas JI
    Eur J Gastroenterol Hepatol; 1995 Mar; 7(3):237-41. PubMed ID: 7538032
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence and incidence of hepatitis C seroconversion in patients on hemodialysis].
    Resić H; Sahović V; Mesić E; Leto E
    Acta Med Croatica; 2003; 57(1):39-42. PubMed ID: 12876861
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hepatitis C infection in dialysis patients in Israel.
    Weinstein T; Tur-Kaspa R; Chagnac A; Korzets A; Ori Y; Zevin D; Herman M; Gafter U
    Isr Med Assoc J; 2001 Mar; 3(3):174-7. PubMed ID: 11303373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibodies to hepatitis C virus (HCV) in chronic renal failure (CRF) patients on conservative therapy: prevalence, risk factors and relationship to liver disease.
    Fabrizi F; Marcelli D; Bacchini G; Guarnori I; Erba G; Locatelli F
    Nephrol Dial Transplant; 1994; 9(7):780-4. PubMed ID: 7526275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detection of antibodies to HCV in haemodialysis patients using two second generation ELISA tests.
    Dentico P; Volpe A; Buongiorno R; Fiore G; Carbone M; Manno C; Pastore G; Schiraldi O
    Ital J Gastroenterol; 1993 Jan; 25(1):19-22. PubMed ID: 7679012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of occult hepatitis B and hepatitis C virus infections in Turkish hemodialysis patients.
    Yakaryilmaz F; Gurbuz OA; Guliter S; Mert A; Songur Y; Karakan T; Keles H
    Ren Fail; 2006; 28(8):729-35. PubMed ID: 17162434
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of hepatitis C virus antibody in patients on chronic hemodialysis.
    Nomiyama K; Tsuji H; Ikeda K; Kawatoko T; Kashiwagi S; Nakamura S; Fujishima M
    Fukuoka Igaku Zasshi; 1998 Aug; 89(8):232-7. PubMed ID: 9778915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prevalence of anti-HCV positivity in patients undergoing haemodialysis or with malignant disease.
    Paydas S; Aksu HS; Paydas S; Burgut R; Sagliker Y
    Br J Clin Pract; 1994; 48(1):25-6. PubMed ID: 8179977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of antibodies to hepatitis C virus in patients on peritoneal dialysis--a multicenter study.
    Gladziwa U; Schlipköter U; Lorbeer B; Cholmakow K; Roggendorf M; Sieberth HG
    Clin Nephrol; 1993 Jul; 40(1):46-52. PubMed ID: 7689431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of hepatitis C virus infection in hemodialysis patients: a longitudinal study comparing the results of RNA and antibody assays.
    Chan TM; Lok AS; Cheng IK; Chan RT
    Hepatology; 1993 Jan; 17(1):5-8. PubMed ID: 7678575
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hepatitis C virus infection in renal dialysis patients in Glasgow.
    McIntyre PG; McCruden EA; Dow BC; Cameron SO; McMillan MA; Allison ME; Briggs JD
    Nephrol Dial Transplant; 1994; 9(3):291-5. PubMed ID: 7519762
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Anti-HCV antibodies among hemodialysed and kidney-transplanted patients].
    Juszczyk J; Flieger J; Syczewska M; Krzymański M
    Przegl Epidemiol; 1994; 48(1-2):3-9. PubMed ID: 8073139
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Decreasing the risk of post-transfusion non-A, non-B hepatitis by anti-HCV screening].
    Holzberger G; Seidl S; Peschke B; Scheuermann EH; Schoeppe W
    Beitr Infusionsther; 1992; 30():46-8. PubMed ID: 1284760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatitis C virus infection in hemodialysis patients].
    Li JS
    Zhonghua Yi Xue Za Zhi; 1992 Nov; 72(11):655-7, 701. PubMed ID: 1284485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.